Entrada Therapeutics, Inc.
NASDAQ:TRDA
15 (USD) • At close September 19, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities: | |||||||||||||||
| Net Income
| 23.496 | -9.544 | 35.461 | -25.928 | -6.674 | -24.629 | -25.137 | -23.179 | -21.671 | -18.447 | -14.43 | -9.901 | -8.38 | -8.673 | -6.99 |
| Depreciation & Amortization
| 0.934 | 0.736 | 0.834 | 0.73 | 0.541 | 0.525 | 0.514 | 0.466 | 0.39 | 0.364 | 0.302 | 0.252 | 0.199 | 0.098 | 0.09 |
| Deferred Income Tax
| 0 | -3.76 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Stock Based Compensation
| 3.733 | 3.841 | 3.396 | 3.119 | 2.755 | 2.882 | 2.707 | 2.512 | 1.794 | 1.458 | 0.578 | 0.326 | 0.164 | 0.098 | 0.075 |
| Change In Working Capital
| -51.645 | 2.953 | -62.331 | -11.321 | 207.014 | -5.979 | -5.536 | 2.05 | -1.646 | -3.837 | -0.678 | 1.413 | -0.319 | 1.84 | 1.18 |
| Accounts Receivables
| -71.636 | -0.853 | -1.281 | 2.553 | -6.297 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Inventory
| 0 | 4.024 | 1.281 | -2.553 | 6.297 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Change In Accounts Payables
| -0.655 | 2.406 | -1.365 | -4.38 | 0.534 | 4.593 | -2.907 | 1.54 | 2.061 | -1.026 | 0.08 | 0.499 | -0.268 | -0.078 | 0.398 |
| Other Working Capital
| 20.646 | -2.624 | -60.966 | -6.941 | 206.48 | -10.572 | -2.629 | 0.51 | -3.707 | -2.811 | -0.758 | 0.914 | -0.051 | 1.918 | 0.782 |
| Other Non Cash Items
| 75.855 | 1.761 | -1.852 | -1.691 | -0.237 | -0.103 | -0.03 | 0.142 | 0.142 | -0.079 | 0.153 | 0 | 0 | 0.013 | 0 |
| Operating Cash Flow
| -25.519 | -4.013 | -24.492 | -35.091 | 203.399 | -27.304 | -27.482 | -18.009 | -20.991 | -20.541 | -14.075 | -7.91 | -8.336 | -6.624 | -5.645 |
| Investing Activities: | |||||||||||||||
| Investments In Property Plant And Equipment
| -0.838 | -0.976 | -1.448 | -1.522 | -1.668 | -0.708 | -0.81 | -0.775 | -0.594 | -1.322 | -0.806 | -1.544 | -0.908 | -1.451 | -0.237 |
| Acquisitions Net
| 0 | -152.8 | 2.289 | 111.735 | 38.776 | 0 | 9.324 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Purchases Of Investments
| -96.935 | -88.521 | -76.789 | -140.121 | -101.776 | 0 | -39.324 | 0 | -182.653 | 0 | 0 | 0 | 0 | 0 | 0 |
| Sales Maturities Of Investments
| 123.92 | 108.54 | 74.5 | 28.386 | 63 | 19.5 | 30 | 25 | 1.714 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activites
| 26.985 | 20.019 | -2.289 | -111.735 | -38.776 | 19.5 | -9.324 | 25 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investing Cash Flow
| 26.147 | 19.043 | -3.737 | -113.257 | -40.444 | 18.792 | -10.134 | 24.225 | -181.533 | -1.322 | -0.806 | -1.544 | -0.908 | -1.451 | -0.237 |
| Financing Activities: | |||||||||||||||
| Debt Repayment
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Issued
| 0.206 | 0.69 | 0.368 | 0.443 | 19.536 | 0.358 | 0.06 | 0.011 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Common Stock Repurchased
| 0 | 0.443 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividends Paid
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities
| 0.206 | 0.69 | 0.368 | 0.443 | 19.536 | 0.358 | 0.06 | 0.011 | 0.05 | 190.755 | 0.106 | 0 | 0 | 0.149 | 24.864 |
| Financing Cash Flow
| 0.206 | 0.69 | 0.368 | 0.443 | 19.536 | 0.358 | 0.06 | 0.011 | 0.05 | 190.755 | 0.106 | 0.215 | 116.385 | 0.149 | 24.864 |
| Other Information: | |||||||||||||||
| Effect Of Forex Changes On Cash
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Change In Cash
| 0.834 | 15.72 | -27.861 | -147.905 | 182.491 | -8.154 | -37.556 | 6.227 | -202.474 | 168.892 | -14.775 | -9.239 | 107.141 | -7.926 | 18.982 |
| Cash At End Of Period
| 68.436 | 67.602 | 55.832 | 83.693 | 231.598 | 49.107 | 57.261 | 94.817 | 88.59 | 291.064 | 122.172 | 136.947 | 146.186 | 39.045 | 46.971 |